Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Procter & Gamble (PG)

P&G executive Jennifer Davis to retire as Health Care CEO effective June 30, 2026

Neutral Impact 3 of 5 leadership Written later

Procter & Gamble said Jennifer Davis, its Chief Executive Officer - Health Care, notified the company on December 9, 2025 of her intent to retire effective June 30, 2026, after more than 33 years of service. The filing does not name a successor or describe any change to compensation, so shareholders should note a senior leadership transition in one of the company's business units.

Key points

  • Jennifer Davis, Chief Executive Officer - Health Care, notified P&G of her retirement on December 9, 2025
  • Retirement is effective June 30, 2026
  • Davis has more than 33 years of service with the company
  • The filing does not name a successor

The filing

CompanyProcter & Gamble (PG)
Form8-K, current report
Filed with the SECDec 15, 2025, 9:15 AM ET
Accession number0000080424-25-000287

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 15, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.